Skip to main navigation Skip to search Skip to main content

Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography

  • Erdal Cavusoglu
  • , Jonathan D. Marmur
  • , Sudhanva Hegde
  • , Sunitha Yanamadala
  • , Olcay A. Batuman
  • , Vineet Chopra
  • , Gonca Ay
  • , Calvin Eng

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Abstract

Objectives: To investigate the long-term prognostic significance of baseline plasma MMP-1 levels in a group of well-characterized male patients with known or suspected coronary artery disease, including those presenting with acute coronary syndrome. Background: MMP-1 is an interstitial collagenase that is considered the primary enzyme responsible for collagen degradation. In addition, MMP-1 can lead to platelet activation through the PAR1 pathway that is independent of thrombin. Methods: Baseline plasma MMP-1 levels were measured in 364 male patients who were referred for coronary angiography and followed prospectively for five years for the development of all-cause mortality. Results: After adjustment for a variety of baseline clinical, angiographic and laboratory parameters, baseline plasma MMP-1 levels (analyzed as a continuous variable) were an independent predictor of all-cause mortality at 5 years (HR, 1.49; 95% CI, 1.23-1.80; P<0.0001). Furthermore, in 3 additional multivariate models that included a wide variety of contemporary biomarkers with established prognostic efficacy (i.e., ST2, GDF-15, Cystatin C, hs-CRP, Myeloperoxidase, NT-proBNP, TIMP-1, Adiponectin, RDW, hemoglobin, and Erythropoietin), MMP-1 remained an independent predictor of all-cause mortality at 5 years. Similar results were obtained when the analyses were restricted to the subpopulation of patients presenting with acute coronary syndrome. Conclusions: Elevated levels of MMP-1 are associated with an increased risk of long-term all-cause mortality in patients with known or suspected coronary disease that is independent of a variety of clinical, angiographic, and laboratory variables, including a whole host of contemporary biomarkers with established prognostic efficacy representing multiple different pathophysiologic processes.

Original languageEnglish
Pages (from-to)268-275
Number of pages8
JournalAtherosclerosis
Volume239
Issue number1
DOIs
StatePublished - 1 Mar 2015
Externally publishedYes

Keywords

  • Acute coronary syndrome
  • Biomarkers
  • Matrix metalloproteinase 1
  • Mortality
  • Prognosis

Fingerprint

Dive into the research topics of 'Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography'. Together they form a unique fingerprint.

Cite this